Antithrombotic prophylaxis of no benefit in symptomatic outpatients with COVID-19: Lancet
Delhi: Results from two randomized trials indicate that routine use of antithrombotic therapies to prevent thromboembolic complications is futile among symptomatic outpatients with COVID-19. The...
Region Flamande Stefano Barco Department Of Cardiology University Hospital Zurich Department Of Angiology Frank Cools
Source: medicaldialogues.in